D-dimer
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Emergency Medicine Pulmonary Embolism Testing Multicentre Study
Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival
Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.
D-dimer Levels in Pregnant With COVID-19
Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism